cor2ed
engage checkpoint medical linkedin twitter
bg

New therapies for metastatic hormone sensitive prostate cancer

New therapies for metastatic hormone sensitive prostate cancer

Prof. David Pfister

As an experienced urologist and member of GU CONNECT, Prof. David Pfister provides his perspective on new therapies for mHSPC.
Portrait of David Pfister
Prof. David Pfister

Urologist

University Hospital of Cologne

Germany

preview next

time Expert View | open 5 min

download resources

I agree that this educational programme:

Was valuable to me:

1/3

Other programmes of interest